Perspective Therapeutics, Inc.Perspective Therapeutics, Inc.Perspective Therapeutics, Inc.

Perspective Therapeutics, Inc.

No trades
No trades

Fundamentals and stats

EPS and revenue snapshot

In the last quarter, the company reported −0.25 USD per share, beating the −0.29 USD estimate by 14.83%. Revenue for the same period reached ‪76.00 K‬ USD, despite the estimate of ‪157.38 K‬ USD. For the next quarter, analysts expect −0.25 USD in earnings per share and ‪90.53 K‬ USD in revenue.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise